From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Wed, 19 Feb 2020 00:23:40 +0000
To: Eisinger, Robert (NIH/NIAID) [E]
Subject: FW: New England Journal of Medicine - 20-02387

FYI. Just to keep an eye on this. Thanks.

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone: "Gy GF

   

 

should not be used by anyone who is not the original intended recipient. If you have received this e-mail in error
please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of
Allergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's own
and not expressly made on behalf of the NIAID by one of its representatives.

----- Original Message-----

From: New England Journal of Medicine <onbehalfof@manuscriptcentral.com>

Sent: Tuesday, February 18, 2020 10:41 AM

To: Fauci, Anthony (NIH/NIAID) [E] Q)
~_: (vb) (6}>; Redfield, Robert R. (CDC/OD)

Subject: New England Journal of Medicine - 20-02387

  

(63; Lane, Cliff (NIH/NIAID) [E]
mm

Dear Dr. Fauci,

Thank you for submitting your manuscript, "COVID-19 : Navigating the Unchartered" to the New England Journal
of Medicine.

Your manuscript has been forwarded to members of our editorial staff, who will make an initial evaluation and
decide whether it merits further consideration. You will be notified of the decision as soon as possible.

Your manuscript ID is 20-02387.

Please mention the above manuscript ID in all future correspondence or when calling the office for questions. If
there are any changes in your street address or e-mail address, please log in to ScholarOne Manuscripts at
https://mc05.manuscriptcentral.com/nejm and edit your user information as appropriate. You may also view the
status of your manuscript at any time by checking For Authors section of the site.

We are undertaking evaluation of your manuscript with the understanding that neither the substance of the article
nor the figures or tables have been published or will be submitted for publication elsewhere during the period of
review.

Please provide the editors with copies of other manuscripts by you or your coauthors addressing similar or related

research questions that are in preparation or under consideration at other journals. This does not apply to abstracts
published in connection with scientific meetings or to news reports based on presentations at such meetings.

The Journal's policy is explained more fully at http://www.nejm.org/page/author-center/editorial-policies.

NIH-001773
